Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
27 June 2016 08:57
Thousands of new skin cancer cases are diagnosed every year
Over 1,000 Welsh and English skin cancer patients could receive a revolutionary new, life-prolonging drug combination that has been fast-tracked for use in the NHS.
The Yervoy (ipilimumab) and Opdivo (nivolumab) mixture uses the body's immune system to fight tumours.
Tests show that over six in 10 of 95 skin cancer sufferers given the treatment remained alive two years later. Of these, 22% were tumour-free.
Few drugs have ever been approved faster in the history of the NHS.
Nice sanctioned the drugs just weeks after the European Medicines Agency granted them a licence.
The combination is targeted at patients suffering from melanoma which has dispersed throughout their bodies.
Scientists say the pair can ward off advanced melanoma's development by a typical eight months in contrast with conventional treatment.
Experts believe that roughly 1,300 patients could qualify to use these immunotherapy drugs each year.
Both drugs are called "checkpoint inhibitors". These disturb two separate signalling pathways and basically free up a person's immune system to tackle tumours.
These inhibitors are known to cause liver damage, diarrhoea and other side-effects, however.
Foreign holidays
Patients diagnosed with the disease need not rule out holidays abroad, especially if they take out skin cancer-related travel insurance.
Policies comprise round-the-clock medical help and replacement medication.
Key stats
• Melanoma claims 1,750 English lives each year
• Latest stats show that 12,200 new cases of skin cancer were detected in 2013
• Skin cancer sufferers can typically only expect to live under two years after being diagnosed.
21 September 2018
UK holidaymakers could be missing out on more than 60 direct flight routes thanks to Air Passenger Duty (APD), a report suggests.
[more...]
20 September 2018
Living in areas with high levels of air pollution could be linked to an increased risk of dementia, new research suggests.
19 September 2018
Multiple sclerosis (MS) patients are shelling out tens of thousands of pounds for care - and many are unable to cover the costs, a leading charity has warned.
18 September 2018
As much as £6 of every £10 spent on domestic flights in the UK goes on Air Passenger Duty (APD), new research suggests.
15 September 2018
UK driving licences might become invalid in certain European countries if the UK crashes out of the EU with no deal, the Government has warned.
14 September 2018
Online crowdfunding for cancer treatments is indirectly advancing the rise of alternative "quack" therapies, experts have warned.
13 September 2018
A "wee-stick" like those used in pregnancy testing could be employed to prevent thousands of deaths from ovarian cancer.
11 September 2018
As many as 1.3 million passengers endured severe flight delays in the last year, a new study reveals.
08 September 2018
British Airways customers are cancelling their credit cards after the carrier was hit by a 15-day data breach that compromised the details of around 380,000 people.
06 September 2018
Plastic trays at security desks harbour the highest numbers of viruses at airports, new research has discovered.
05 September 2018
Adults are being urged to take advantage of a new online tool to find out if they are at risk of having a heart attack or stroke.
04 September 2018
Child cancer patients regularly have to travel twice as far and pay out twice as much when getting treatment, new data shows.